PORTFOLIO

  • FIH
  • R&D
Delivery Pipeline POC Pre-IND IND Phase Ⅰ Phase Ⅱ/Ⅲ
β-thalassemia
Sickle cell disease
Hypertriglyceridemia/Familial chylomicronemia
ASCVD/Hyperlipoproteinemia
Homozygous Familial Hypercholesterolemia
Inherited metabolic disorder
Inherited metabolic disorder
Non-liver targeting
CorrectSequence Therapeutics Co., Ltd. © (2021-2026)

沪ICP备2020032248号-1

Powered by MetInfo 7.7 ©2008-2026  mituo.cn
HOME
ABOUT
NEWS
CONTACT